Epidemiological study of adverse events following immunization in under 5 year children

Background: The present study was conducted to study the socioeconomic and the demographic profile of children reporting with adverse events following immunization (AEFI) along with the determinants associated with AEFIs, based on investigation of each case and to assess the proportion of programmat...

Full description

Bibliographic Details
Main Authors: Vikrant S Pagar, Sushant S Chavan, Sarika P Patil, Anant Borde, Amol D Kinge, Naveen Khargekar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=7;spage=2482;epage=2487;aulast=Pagar
id doaj-69ce26d744d640ca9065a4c658e2dd17
record_format Article
spelling doaj-69ce26d744d640ca9065a4c658e2dd172021-08-09T09:56:23ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632021-01-011072482248710.4103/jfmpc.jfmpc_2328_20Epidemiological study of adverse events following immunization in under 5 year childrenVikrant S PagarSushant S ChavanSarika P PatilAnant BordeAmol D KingeNaveen KhargekarBackground: The present study was conducted to study the socioeconomic and the demographic profile of children reporting with adverse events following immunization (AEFI) along with the determinants associated with AEFIs, based on investigation of each case and to assess the proportion of programmatic errors linked with AEFI cases. Materials and Methods: Record-based cross–sectional study conducted among sample of 118 cases of AEFI were reported. The case reports of all AEFI cases were procured and analyzed to identify factors associated with reported AEFI. The questionnaires related with preliminary investigation reports (PIRs) including forensic evidence of death cases were analyzed. Percentage analysis of data was done by proportions, measures of central tendencies, and Chi-square test. Results: Most of the cases reported were between 0 and 3 months of age constituting 39%. AEFI was seen more in male child than female. more than half of cases of AEFI were recorded following immunization with OPV/DPT/HBV together (66.94%). Most common AEFI reported were convulsion (68.64 %) and fever (58.47%) followed by local swelling at site of injection (11.86%). More than half of the cases of AEFI occurred within 12 hours of immunization (61.88%). Birth weight of most cases of AEFI were in the range between 2 and 2.4 kg (44.06%), followed by range between 2.5 and 2.9 kg (32.20%), the mean of birth weight was 2.51 kg. Conclusion: Convulsion was the most commonly reported AEFI, majority of AEFI occur within 12 h of immunization. Most of the AEFI were recorded following immunization with OPV/DPT/HBV together.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=7;spage=2482;epage=2487;aulast=Pagaraefiimmunization
collection DOAJ
language English
format Article
sources DOAJ
author Vikrant S Pagar
Sushant S Chavan
Sarika P Patil
Anant Borde
Amol D Kinge
Naveen Khargekar
spellingShingle Vikrant S Pagar
Sushant S Chavan
Sarika P Patil
Anant Borde
Amol D Kinge
Naveen Khargekar
Epidemiological study of adverse events following immunization in under 5 year children
Journal of Family Medicine and Primary Care
aefi
immunization
author_facet Vikrant S Pagar
Sushant S Chavan
Sarika P Patil
Anant Borde
Amol D Kinge
Naveen Khargekar
author_sort Vikrant S Pagar
title Epidemiological study of adverse events following immunization in under 5 year children
title_short Epidemiological study of adverse events following immunization in under 5 year children
title_full Epidemiological study of adverse events following immunization in under 5 year children
title_fullStr Epidemiological study of adverse events following immunization in under 5 year children
title_full_unstemmed Epidemiological study of adverse events following immunization in under 5 year children
title_sort epidemiological study of adverse events following immunization in under 5 year children
publisher Wolters Kluwer Medknow Publications
series Journal of Family Medicine and Primary Care
issn 2249-4863
publishDate 2021-01-01
description Background: The present study was conducted to study the socioeconomic and the demographic profile of children reporting with adverse events following immunization (AEFI) along with the determinants associated with AEFIs, based on investigation of each case and to assess the proportion of programmatic errors linked with AEFI cases. Materials and Methods: Record-based cross–sectional study conducted among sample of 118 cases of AEFI were reported. The case reports of all AEFI cases were procured and analyzed to identify factors associated with reported AEFI. The questionnaires related with preliminary investigation reports (PIRs) including forensic evidence of death cases were analyzed. Percentage analysis of data was done by proportions, measures of central tendencies, and Chi-square test. Results: Most of the cases reported were between 0 and 3 months of age constituting 39%. AEFI was seen more in male child than female. more than half of cases of AEFI were recorded following immunization with OPV/DPT/HBV together (66.94%). Most common AEFI reported were convulsion (68.64 %) and fever (58.47%) followed by local swelling at site of injection (11.86%). More than half of the cases of AEFI occurred within 12 hours of immunization (61.88%). Birth weight of most cases of AEFI were in the range between 2 and 2.4 kg (44.06%), followed by range between 2.5 and 2.9 kg (32.20%), the mean of birth weight was 2.51 kg. Conclusion: Convulsion was the most commonly reported AEFI, majority of AEFI occur within 12 h of immunization. Most of the AEFI were recorded following immunization with OPV/DPT/HBV together.
topic aefi
immunization
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=7;spage=2482;epage=2487;aulast=Pagar
work_keys_str_mv AT vikrantspagar epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren
AT sushantschavan epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren
AT sarikappatil epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren
AT anantborde epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren
AT amoldkinge epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren
AT naveenkhargekar epidemiologicalstudyofadverseeventsfollowingimmunizationinunder5yearchildren
_version_ 1721214383338553344